Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Medico Remedies Ltd

MEDICO.NS ✓ COMPLIANTFree checks used up today ☆ Track — members

NSE · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$0.20

▼ -5.88%

Market Cap $16.77M · Vol 229.33K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

11.46

FWD: N/A

Market Cap

$16.77M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

28.09

Momentum

Beta

1.68

vs Market

52W High

$0.60

68.14% below

52W Low

$0.20

2.23% above

Volume

229.33K

Avg 507.90K

P/B

3.60

Price-to-book

ROE

N/A

Return on equity

Free Float

31.79%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Medico Remedies Ltd (MEDICO.NS) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MEDICO.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-7.51%

-13.81%

-55.86%

-52.28%

YTD

-62.02%

-60.14%

-76.85%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$22.08M
Net Income	$1.40M
Revenue Growth (YoY)	+81.43%
Gross Margin	18.16%
Operating Margin	6.75%
Net Profit Margin	6.35%
ROE	N/A
ROA · ROIC	13.22% · 15.39%

P/E Ratio	11.46
Forward P/E (FY1)	N/A
PEG Ratio	0.69
P/S	1.32
P/B	3.60
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	82.98M

Technical Indicators

50-Day SMA	$0.33
200-Day SMA	$0.42
RSI (14)	28.09
Beta	1.68
52-Week High	$0.60
52-Week Low	$0.20

Volume Today	229.33K
Avg Daily Volume (30D)	507.90K
Relative Volume	0.45x
Volatility (10D)	36.13
Volatility (30D)	80.58
Free Float	31.79%

Analyst Consensus

N/A

Current Price $0.20

Mean Target N/A

52W Low$0.20 52W High$0.60

Current

Target

$0.20 $0.60

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE

FIGIBBG00JVDFY31

ISININE630Y01024

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Company +0.50% JNJ Johnson & Johnson +0.86% ABBV AbbVie Inc. -0.14% NVS Novartis AG -0.50% NOVN.S Novartis AG +0.34%

Company Profile

Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, hematinic and other supplements. The Company also manufactures and markets capabilities in other drugs such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Pediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others. Its syrups include Medivit Syrup and Ferrovit Syrup.